The Arsenal Isn't Built at the Airshow. It's Built in Factories Nobody Visits.
A quick note from Behind the Markets
Wall Street keeps buying "defense" like it's a two-stock trade.
They want the shiny primes. The big logos. The press-release winners.
But modern conflict is a supply-chain grind. And the money sticks to the parts of the machine that are scarce, regulated, and hard to scale.
It's Saturday — markets closed, time to study. All week we've been mapping the layers beneath the primes. Today we go to the deepest three: the companies that make missiles possible, the testers who certify everything works, and the expendables that get used up and reordered. Fair warning: all three of today's stories include the ugly parts — crashes, lawsuits, and valuation fights — because that's what this layer of the market actually looks like.
1) The Next Defense Boom Is a Manufacturing Boom (And It Won't Be Pretty)
If you want the real defense signal, stop watching airshow clips. Watch the factory floor.
The U.S. and allies are trying to expand production capacity fast — missiles, drones, air defense, sensors, and munitions. That's not a one-quarter story. It's a multi-year capex cycle with bottlenecks everywhere: tooling, specialized metals, energetic materials, electronics, and testing.
And here's your case study in what "won't be pretty" means — a company whose business went straight up while its stock did a round trip that would make a rollercoaster engineer dizzy.
Company: Karman Holdings (SYM: KRMN)
The missile-and-hypersonics component specialist — the thesis kept working while the stock crashed 58%. Now the two are renegotiating.
Karman makes the unglamorous essentials of the missile age: payload protection and deployment systems, aerodynamic interstage structures, and propulsion systems for hypersonics, strategic missile defense, tactical missiles, and space launch. Throughput incarnate. The business has performed: revenue surged 47% year over year in its latest reported quarter, with a record backlog of $801 million, up 38%.
Now the honest chart history: Karman IPO'd at $30 in February 2025, rode the defense mania to $118 by March — up 171% in a year, at a valuation north of $13 billion on roughly $345 million of trailing revenue — and then reality collected: a 14-million-share secondary offering priced at $61 in late May (the private-equity sponsors cashing out — the second holder sell-down of the spring), the Blue Origin launch explosion hammering space suppliers, and valuation-driven target cuts (Citi to $76 from $97, still Buy, with an "upside 90-day catalyst watch"), leaving the stock down as much as 58% from its high. And then July turned constructive again: inclusion in the S&P SmallCap 600 effective July 17, a $21.3 million Northrop Grumman contract award, a $94 million acquisition of Glasgow's Walker Precision to expand internationally, and a Pennsylvania facility expansion.
The two-sided file: even after the crash, this is an expensive stock at $47(double-digit multiples of sales, thin profits — trailing net income of just $12.7 million), the sponsor overhang is documented and may not be finished, and it's a recent IPO with exactly one full year of public history. What you're buying is the energetics-and-components bottleneck at half its bubble price, with index inclusion and contract flow as fresh support. Speculative sizing, weekend homework first.
Bottom line: The defense trade is morphing from "platforms" to "throughput." The winners are the companies that enable volume — just don't pay bubble prices for the privilege.
2) The Underfollowed Defense Angle: Compliance + Quality Assurance = Pricing Power
Here's why "boring" defense suppliers can be better investments than the glamour names: defense procurement has a killer feature — qualification. Once you're qualified, switching costs are real. Paperwork is real. Audit trails are real. And failure is not an option.
Want to see what a qualification moat looks like in a press release? It looks like this.
Company: Astronics (SYM: ATRO)
Aircraft power systems and military test equipment from East Aurora, New York — where a single Army purchase order proves the whole thesis.
Astronics runs two businesses that both live inside the moat: an Aerospace segment making power generation and distribution systems — the ruggedized electronics inside commercial and military aircraft — and a Test Systems segment building automated test equipment for aerospace, defense, communications, and mass transit. Here's the thesis in one item: the U.S. Army issued a purchase order initiating full-rate production for Astronics' TS-4549/T Radio Test Sets program. Read that as a civilian: the Army qualified this company's test equipment, and now every radio has to pass through it. That's not a sale. That's an annuity with a security clearance.
The operating momentum is verified and loud: first-quarter sales rose 12% to $230.6 million with net income of $25.5 million, record quarterly bookings of $290.4 million driving backlog to a record $734.3 million, and a raised full-year outlook of $970 million to $1 billion. TD Cowen raised its target to $100 from $85 at Buy.
Now the disclosures, and there are three. First, the run: this stock has roughly tripled from its early-2025 levels — the market found the turnaround — so the easy rerating is behind it and the multiple is demanding. Second, a housekeeping trap: Astronics distributed one share of non-tradable Class B stock for every five shares held in late June, which mechanically adjusted the common share price — so price charts spanning June are misleading; compare only post-distribution quotes. Third, and most important: Astronics reports second quarter results on August 11th. Depending on the numbers, the stock could reprice sharply. Commercial aerospace cyclicality (its airline-cabin power business rides airline capex) and a historically thin-margin past round out the risk file. A moat, fairly discovered, freshly reported — but consider letting the report numbers set your entry judgment.
Bottom line: If you can't be replaced easily, you can raise prices quietly — and that's how small caps compound.
3) The Drone Reality Check: Attrition Means Recurring Demand
Drones are getting treated like a "tech trend." They aren't. They're expendable systems. Attrition is the business model — recurring demand for airframes, propulsion, batteries, guidance, anti-jam tech, and training.
The market will eventually figure this out. Meanwhile, the definitive company in this space just gave investors a full tour of what "not priced correctly" feels like — in both directions, in five months.
Company: AeroVironment (SYM: AVAV)
(Note: we covered this name in an earlier cycle, but both the company and the price have transformed since.)
The Switchblade maker — now a multi-domain drone and counter-drone company — down 65% from its March high, with booming demand and a lawsuit overhang. This is the attrition trade with its makeup off.
The business case first, because it's the strongest: AeroVironment makes the Switchblade loitering munitions that have become fixtures of modern warfare — bought, used, destroyed, reordered — and after acquiring BlueHalo, it now fights both sides of the drone war: its counter-drone business generated about $200 million in fiscal 2026, and management expects rapid growth as knocking enemy drones down becomes as urgent as launching them. Attrition on offense, attrition on defense. The demand is verifiable: fiscal fourth-quarter revenue jumped 133% to a record $641.6 million — a 28% single-day stock surge on the beat, with backlog reaching $1.2 billion — plus a July parade of exactly the "surprisingly strong order flow" the draft predicts: a $117.3 million U.S. Army P550 deal, Italy's military designation for its JUMP aircraft, a $500 million Army Titan RF counter-drone contract, and rising odds of a $500 million Army laser award as soon as the September quarter.
Now the full honest file, because this stock is a masterclass in violence: shares peaked near $417 in March, and despite everything above, they traded at $147 this week — down roughly 65% — as EBITDA estimates reset materially lower (prompting Raymond James to upgrade to Outperform at $210 precisely because of the decline) and July target cuts landed even from bulls: BofA to $225 from $450, Citizens to $230 from $350, Canaccord to $240. And the disclosure that must be in plain sight: securities class-action lawsuits have been filed alleging misrepresentations regarding the company's $1.7 billion SCAR contract — an unresolved legal overhang with real reputational and financial stakes. Add GAAP losses from acquisition charges and you have the setup: consensus targets in the $210–260 range against a $147 stock, a booming order book, an angry tape, and a courtroom. Next earnings aren't until September 9, so the near-term catalysts are contracts and headlines, not prints. If you buy the attrition thesis — this is where it trades when nobody's romanticizing it. Speculative sizing; the lawsuit risk is not decoration.
Bottom line: Expendable systems create repeat business. The Street still models them like one-time sales — and periodically panics in both directions while it learns.
4) The Risk Nobody Prices: Supply Chains as a Weapon
Geopolitics is turning supply chains into leverage. If your key inputs run through adversarial jurisdictions — or fragile shipping lanes — you don't have a moat. You have a vulnerability.
Here's the weekend checklist for every defense-adjacent name you own, including today's three:
Where do inputs come from? Thursday's issue showed you tungsten — China restricted it, and the one U.S. toolmaker with tungsten in its name repriced overnight. Every company has a tungsten. Find it in the 10-K's supply-chain risk section.
Can production move onshore? Karman just bought a Scottish precision manufacturer; Astronics is consolidating operations domestically. Watch where the capex goes — it's a confession of where the vulnerabilities were.
Is there a single-source failure point? This cuts both ways: single-source suppliers are the risk; single-source positions (like a test set the Army qualified) are the moat. The same sentence in a filing can be a red flag or a treasure map depending on which side of it the company sits.
Bottom line: Reliability is becoming a national-security product. That's bullish for domestic, qualified suppliers — and it's a question you can answer from a kitchen table with a 10-K and a Saturday morning.
Before You Go
Wall Street wants "defense" to stay a headline trade.
Don't play their game.
Follow the constraints: certification, throughput, and the ugly industrial plumbing that makes the arsenal real. Today you saw all three with their scars showing — a components maker that round-tripped a bubble, a qualified tester that tripled and just reported, and the attrition franchise trading 65% off its high with lawyers circling. Every risk is in plain text above. That's the deal in this layer of the market: the moats are real, and so are the potholes.
Study it this weekend. The contracts page updates Monday.
Found this helpful? Share it with others.
Written by Behind the Markets